GlaxoSmithKline: all 4,196 studies
Page 7 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of AgeCompletedNCT02979639Phase 3Results posted
- Exploratory Study to Investigate Cognition Function and Mobility in Individuals With PainTerminatedNCT02974114Phase 4Results posted
- A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)CompletedNCT02969655Phase 3Results posted
- Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary CholangitisCompletedNCT02966834Phase 2Results posted
- Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3117391 in Subjects With Rheumatoid ArthritisTerminatedNCT02965599Phase 2Results posted
- Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast CancerTerminatedNCT02964507Phase 1Results posted
- A Study to Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult WomenCompletedNCT02956837Phase 2Results posted
- Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected AdultsActive, not recruitingNCT02951052Phase 3Results posted
- Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in AdolescentsCompletedNCT02946385Phase 2Results posted
- Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive ParticipantsActive, not recruitingNCT02938520Phase 3Results posted
- A Bite Force Study Comparing Two New Test Adhesives With Currently Marketed Denture AdhesiveCompletedNCT02937870Not applicableResults posted
- To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese PopulationCompletedNCT02937636Not applicableResults posted
- To Evaluate the Efficacy of an Experimental Dissolvable Strip in Rapidly Relieving Dentinal Hypersensitivity (DH)CompletedNCT02937623Not applicableResults posted
- Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)TerminatedNCT02929498Phase 1/2Results posted
- Evaluation of a Experimental Denture Adhesive to Prevent Food IngressCompletedNCT02928380Not applicableResults posted
- A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive InfantsCompletedNCT02927873Phase 1/2Results posted
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus SubjectsCompletedNCT02927457Phase 1Results posted
- Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With InfluenzaTerminatedNCT02927431Phase 2Results posted
- A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled AsthmaCompletedNCT02924688Phase 3Results posted
- The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity (DH)CompletedNCT02924350Not applicableResults posted
- To Investigate the Efficacy of an Occluding Dentifrice in Dentinal Hypersensitivity (DH)CompletedNCT02923895Phase 4Results posted
- Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 WeeksCompletedNCT02914184Phase 3Results posted
- Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy InfantsCompletedNCT02907216Phase 4Results posted
- GSK2982772 Study in Subjects With Ulcerative ColitisCompletedNCT02903966Phase 2Results posted
- Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-BCompletedNCT02901951Phase 4Results posted
- A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS PtsCompletedNCT02899377Not applicableResults posted
- Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza VaccinesCompletedNCT02893878Results posted
- Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a YearCompletedNCT02889809Phase 4Results posted
- Prevalence, Strain Circulation and Disease Burden Study of Seasonal Influenza A and B in Panama, Selected Countries of Central America and the Caribbean From the Year 2010 to 2015CompletedNCT02885246Results posted
- Belimumab Phase I Study in Chinese Subjects With Systemic Lupus ErythematosusCompletedNCT02880852Phase 1Results posted
- Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)CompletedNCT02879305Phase 3Results posted
- Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)CompletedNCT02876835Phase 3Results posted
- Asthma Control Test Guided Treatment in Chinese SubjectsCompletedNCT02868281Phase 4Results posted
- Assessment of the Efficacy of an Experimental Occlusion Technology Dentifrice in Dentinal HypersensitivityCompletedNCT02861664Not applicableResults posted
- Motivation, Brain Function and Mood in Individuals With Cold and/or FluTerminatedNCT02860169Not applicableResults posted
- Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)CompletedNCT02858492Phase 2Results posted
- A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in RussiaCompletedNCT02858440Phase 3Results posted
- A Study to Investigate the Antimicrobial Activity of 2 Test ToothpastesCompletedNCT02856880Not applicableResults posted
- Drug Utilization Study for Pirinase Hayfever ReliefCompletedNCT02856282Results posted
- Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-deliveryCompletedNCT02853929Phase 4Results posted
- To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.CompletedNCT02853435Phase 1Results posted
- Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor OveractivityCompletedNCT02849418Phase 3Results posted
- Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain.CompletedNCT02838407Not applicableResults posted
- Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)CompletedNCT02836496Phase 3Results posted
- Effect of the GSK2245035 on the Allergen-induced Asthmatic ResponseCompletedNCT02833974Phase 2Results posted
- Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal HypersensitivityCompletedNCT02832375Phase 3Results posted
- An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)CompletedNCT02831764Phase 3Results posted
- An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)CompletedNCT02831673Phase 3Results posted
- Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating AgentsCompletedNCT02829320Phase 3Results posted
- A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 in Healthy Male SubjectsCompletedNCT02829307Phase 1Results posted
- Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive CoughCompletedNCT02822287Phase 3Results posted
- Efficacy and Safety of GSK1358820 in Subjects With Overactive BladderCompletedNCT02820844Phase 3Results posted
- A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy SubjectsTerminatedNCT02802514Phase 4Results posted
- Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) MalariaCompletedNCT02802501Phase 3Results posted
- Immune Profile in Subjects With New Onset Type 1 DiabetesCompletedNCT02801942Not applicableResults posted
- An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD PatientsCompletedNCT02799784Phase 4Results posted
- Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid ArthritisCompletedNCT02799472Phase 2Results posted
- A Phase I, 2-part (Part 1 Being a Single Dose Escalation and Part 2, a Parallel Group) Study of Toll-like Receptor (TLR4) Agonist (GSK1795091) in Healthy SubjectsCompletedNCT02798978Phase 1Results posted
- A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During InfancyCompletedNCT02798952Phase 4Results posted
- A Phase 1/2 Trial of SRA737 in Subjects With Advanced CancerCompletedNCT02797964Phase 1/2Results posted
- Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct UseCompletedNCT02794480Phase 4Results posted
- An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus SubjectsTerminatedNCT02793154Phase 4Results posted
- Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal AnemiaCompletedNCT02791763Phase 3Results posted
- Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02786927Phase 4Results posted
- An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's LymphomaCompletedNCT02783300Phase 1Results posted
- Frequency of Denture Cleanser Use and Denture CleanlinessCompletedNCT02780661Not applicableResults posted
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With PsoriasisCompletedNCT02776033Phase 2Results posted
- Study to Investigate the Efficacy of an Occluding Dentifrice in Providing Relief From Dentine HypersensitivityCompletedNCT02773758Phase 4Results posted
- Dentine Tubule Occlusion Assessment in a Modified in Situ ModelCompletedNCT02768194Not applicableResults posted
- This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast AsiaTerminatedNCT02766088Not applicableResults posted
- Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 YearsCompletedNCT02757963Phase 4Results posted
- A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.CompletedNCT02757950Results posted
- Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy WomenCompletedNCT02753413Phase 2Results posted
- A Study in Dentinal Hypersensitivity (DH) Participants to Assess the Efficacy of an Occluding Dentifrice.CompletedNCT02753075Not applicableResults posted
- Impact of Long Term Management of Dentine Hypersensitivity (DH) With a Daily Use Anti-sensitivity Toothpaste on the Quality of Life Related to Oral HealthCompletedNCT02752958Not applicableResults posted
- The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity(DH)CompletedNCT02751450Not applicableResults posted
- A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830TerminatedNCT02751424Phase 1Results posted
- Efficacy of Three Toothpastes Using an in Situ Caries ModelCompletedNCT02751320Not applicableResults posted
- Potential of Stannous Fluoride Toothpaste to Reduce Gum DiseaseCompletedNCT02750943Not applicableResults posted
- Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus SubjectsTerminatedNCT02750930Phase 4Results posted
- Safety, Tolerability and Preliminary Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeat Oral Doses of GSK3008356 in Healthy and Obese SubjectsCompletedNCT02742766Phase 1Results posted
- Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and OlderCompletedNCT02735915Phase 3Results posted
- Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal HypersensitivityCompletedNCT02731833Phase 4Results posted
- Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)CompletedNCT02730351Phase 4Results posted
- Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02729051Phase 3Results posted
- Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal FunctionCompletedNCT02729038Phase 1Results posted
- Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)CompletedNCT02723955Phase 1Results posted
- Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal TransplantationTerminatedNCT02723786Phase 2Results posted
- A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older AdultsCompletedNCT02723773Phase 3Results posted
- A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of AgeCompletedNCT02719743Phase 2Results posted
- This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of PanamaCompletedNCT02712359Not applicableResults posted
- A Phase IIA FF/VI Study to Measure FeNO in Asthmatic Patients.CompletedNCT02712047Phase 2Results posted
- Evaluation of a New Thermostable Formulation of FLOLAN in Japanese SubjectsCompletedNCT02705807Phase 4Results posted
- Study Investigating Efficacy of an Occluding Dentifrice for Dentine HypersensitivityCompletedNCT02705716Not applicableResults posted
- Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.CompletedNCT02699099Phase 3Results posted
- Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.CompletedNCT02690207Phase 3Results posted
- Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.CompletedNCT02690181Phase 2Results posted
- Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Switched From a Stable Dose of an Erythropoiesis-stimulating AgentCompletedNCT02689206Phase 2Results posted
- A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy SubjectsCompletedNCT02688387Phase 1Results posted
- A Study to Investigate the Efficacy and Safety of GSK3196165 in Inflammatory Hand OsteoarthritisCompletedNCT02683785Phase 2Results posted